Sale!

PACS1 Gene Mental Retardation Autosomal Dominant Type 17 Genetic Test Cost

Name: PACS1 Gene Mental Retardation Autosomal Dominant Type 17 Genetic Test Cost
SKU: TEST-1579
Price: 4400 AED
Availability: InStock

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PACS1 Gene Mental Retardation Autosomal Dominant Type 17 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the PACS1 gene, which have been associated with a rare form of intellectual disability. This condition, also known as Schuurs-Hoeijmakers syndrome, is characterized by developmental delay, distinctive facial features, and, in some cases, neurological and physical abnormalities. The test is crucial for families seeking a definitive diagnosis for intellectual disability of unknown cause, as it can provide essential information for understanding the condition, guiding management, and assessing the risk of recurrence in future pregnancies. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the comprehensive support provided by DNA Labs UAE, including counseling and interpretation of results.

Description

PACS1 Gene Mental Retardation Autosomal Dominant Type 17 Genetic Test

Test Name: PACS1 Gene Mental Retardation Autosomal Dominant Type 17 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PACS1 Gene Mental Retardation, Autosomal Dominant Type 17 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PACS1 Gene Mental Retardation, Autosomal Dominant Type 17.

Test Details:

The PACS1 gene is associated with mental retardation, autosomal dominant type 17 (MRD17). MRD17 is a genetic condition characterized by intellectual disability and developmental delay. It is inherited in an autosomal dominant manner, meaning that a mutation in one copy of the PACS1 gene is sufficient to cause the condition.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of MRD17, NGS genetic testing can be used to identify mutations or variations in the PACS1 gene that may be responsible for the condition.

NGS genetic testing involves obtaining a DNA sample, usually through a blood or saliva sample, and sequencing the DNA to identify any variations or mutations in the PACS1 gene. This can help in confirming a diagnosis of MRD17 and can also provide valuable information for genetic counseling and family planning.

It is important to note that NGS genetic testing is typically performed by a specialized laboratory and should be ordered and interpreted by a healthcare professional, such as a geneticist or genetic counselor. They can provide more detailed information about the specific testing process, as well as the implications of the test results.

Test Name	PACS1 Gene Mental retardation autosomal dominant type 17 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for PACS1 Gene Mental retardation, autosomal dominant type 17 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PACS1 Gene Mental retardation, autosomal dominant type 17
Test Details	The PACS1 gene is associated with mental retardation, autosomal dominant type 17 (MRD17). MRD17 is a genetic condition characterized by intellectual disability and developmental delay. It is inherited in an autosomal dominant manner, meaning that a mutation in one copy of the PACS1 gene is sufficient to cause the condition. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of MRD17, NGS genetic testing can be used to identify mutations or variations in the PACS1 gene that may be responsible for the condition. NGS genetic testing involves obtaining a DNA sample, usually through a blood or saliva sample, and sequencing the DNA to identify any variations or mutations in the PACS1 gene. This can help in confirming a diagnosis of MRD17 and can also provide valuable information for genetic counseling and family planning. It is important to note that NGS genetic testing is typically performed by a specialized laboratory and should be ordered and interpreted by a healthcare professional, such as a geneticist or genetic counselor. They can provide more detailed information about the specific testing process, as well as the implications of the test results.